Literature DB >> 3068870

Wegener's granulomatosis and autoantibodies to neutrophil antigens.

D R McCluskey, A P Maxwell, L Watt.   

Abstract

We report five cases of Wegener's granulomatosis all of whom had clinical and histological evidence of disease activity at presentation and in whom autoantibodies to neutrophil antigens were detected. This test may prove useful for the diagnosis of this serious condition and help to monitor disease activity during treatment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3068870      PMCID: PMC2448493     

Source DB:  PubMed          Journal:  Ulster Med J        ISSN: 0041-6193


  14 in total

1.  Wegener's granulomatosis: pathology and review of the literature.

Authors:  G C GODMAN; J CHURG
Journal:  AMA Arch Pathol       Date:  1954-12

2.  Wegener's granulomatosis. Long-term followup of patients treated with cyclophosphamide.

Authors:  M J Reza; L Dornfeld; L S Goldberg; R Bluestone; C M Pearson
Journal:  Arthritis Rheum       Date:  1975 Sep-Oct

3.  Wegener's granulomatosis.

Authors:  S M Wolff; A S Fauci; R G Horn; D C Dale
Journal:  Ann Intern Med       Date:  1974-10       Impact factor: 25.391

4.  Wegener's granulomatosis: studies in eighteen patients and a review of the literature.

Authors:  A S Fauci; S M Wolff
Journal:  Medicine (Baltimore)       Date:  1973-11       Impact factor: 1.889

5.  Wegener's granulomatosis: observations on 18 patients with severe renal disease.

Authors:  A J Pinching; C M Lockwood; B A Pussell; A J Rees; P Sweny; D J Evans; N Bowley; D K Peters
Journal:  Q J Med       Date:  1983

6.  Circulating immunoglobulin complexes in Wegener's granulomatosis.

Authors:  S B Howell; W V Epstein
Journal:  Am J Med       Date:  1976-02       Impact factor: 4.965

7.  Objective monitoring of activity in Wegener's granulomatosis by measurement of serum C-reactive protein concentration.

Authors:  C R Hind; C G Winearls; C M Lockwood; A J Rees; M B Pepys
Journal:  Clin Nephrol       Date:  1984-06       Impact factor: 0.975

8.  Cyclophosphamide therapy of severe systemic necrotizing vasculitis.

Authors:  A S Fauci; P Katz; B F Haynes; S M Wolff
Journal:  N Engl J Med       Date:  1979-08-02       Impact factor: 91.245

9.  The use of alkylating agents in the treatment of Wegener's granulomatosis.

Authors:  D Hollander; R T Manning
Journal:  Ann Intern Med       Date:  1967-08       Impact factor: 25.391

10.  An ultrastructural study of the pathogenesis of tissue injury in limited Wegener's granulomatosis.

Authors:  K J Donald; R L Edwards; J D McEvoy
Journal:  Pathology       Date:  1976-04       Impact factor: 5.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.